Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Published Online: 2025-02-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Catherine Thieblemont•Constantine S Tam•David Belada•Edith Szafer-Glusman•Frederic Peyrade•Gottfried von Keudell•James P Dean•Jennifer Lin•Jutta K Neuenburg•Marc Andre•Marc Hoffmann•Marek Trneny•Mary-Margaret Keating•Michael Wang•Nilanjan Ghosh•Ruben Fernandez Alvarez•Tom van Meerten•Tomasz Wrobel•Wojciech Jurczak
